rEVO Biologics, Inc. - FORM 10-Q - EX-32 - SECTION 906 CEO AND CFO CERTIFICATION - November 6, 2009

Attached files

file filename
10-Q - FORM 10-Q - rEVO Biologics, Inc.d10q.htm
EX-10.1 - FORM OF NONSTATUTORY STOCK OPTION AWARD FOR NON-EMPLOYEE DIRECTORS - rEVO Biologics, Inc.dex101.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - rEVO Biologics, Inc.dex312.htm
EX-10.2 - FORM OF NONSTATUTORY STOCK OPTION AWARD - rEVO Biologics, Inc.dex102.htm
EX-10.3 - FORM OF INCENTIVE STOCK OPTION AWARD - rEVO Biologics, Inc.dex103.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - rEVO Biologics, Inc.dex311.htm

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of GTC Biotherapeutics, Inc. (the “Company”) for the quarterly period ended September 27, 2009, as filed with the Securities and Exchange Commission on the date hereof, (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 6, 2009  

/s/ Geoffrey F. Cox

  Geoffrey F. Cox
 

Chairman of the Board, President and

Chief Executive Officer

Date: November 6, 2009  

/s/ John B. Green

  John B. Green
 

Senior Vice President,

Chief Financial Officer and Treasurer

rEVO Biologics, Inc. Reports